A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: A proof of concept study

Biological Psychiatry

Volumn 58, Issue 11, 2005, Pages 865-870

  Brown, E Sherwood ^a   Vigil, Luis ^a   Khan, David A ^b   Liggin, Joshua D M ^a   Carmody, Thomas J ^a   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Asthma; Citalopram; Major depressive disorder; Randomized controlled trial; Selective serotonin reuptake inhibitor

Indexed keywords

CITALOPRAM; CORTICOSTEROID; PLACEBO;

ADULT; APPETITE DISORDER; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG USE; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAUSEA AND VOMITING; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SCORING SYSTEM; SEDATION; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; XEROSTOMIA;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASTHMA; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 29044438207     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.04.030     Document Type: Article

References (52)

1. V. Agosti Predictors of persistent social impairment among recovered depressed outpatients J Affect Disord 55 1999 215 219
2. C.M. Bosley, J.A. Fosbury, G.M. Cochrane The psychological factors associated with poor compliance with treatment in asthma European Respiratory Journal 8 1995 899 904
3. E.S. Brown, D.A. Khan, S. Mahadi Psychiatric diagnoses in inner city outpatients with moderate to severe asthma Int J Psychiatry Med 30 2001 319 327
4. E.S. Brown, D.A. Khan, V.A. Nejtek, N.R. Thomas, S.F. Mahadi Depressive symptoms and functioning in asthma patients Primary Care Psychiatry 6 2000 155 161
5. Centers for Disease Control and Prevention (2001) Self reported asthma prevalence among adults, United States, 2000 MMWR Morb Mortal Wkly Rep 50 2001 682 686
6. E.F. Crain, K.B. Weiss, P.E. Bijur, M. Hersh, L. Westbrook, R.E. Stein An estimate of the prevalence of asthma and wheezing among inner-city children Pediatrics 94 1994 356 362
7. Depression Guideline Panel Clinical Practice Guideline, Number 5: Depression in Primary Care: Volume 2. Treatment of Major Depression 1993 U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research Rockville, MD AHCPR Publication No. 93-0551
8. G.A. Fava, S. Fabbri, N. Sonino Residual symptoms in depression an emerging therapeutic target Prog Neuropsychopharmacol Biol Psychiatry 26 6 2002 1019 1027
9. N. Frasure-Smith, F. Lesperance, M. Talajic Depression and 18-month prognosis after myocardial infarction Circulation 91 1995 999 1005
10. J.F. Greden, R. Gardner, D. King, L. Grunhaus, B.J. Carroll, Z. Kronfol Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility Archives of General Psychiatry 40 1983 493 500
11. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
12. M. Hamilton Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 6 1967 278 296
13. M. Hery, A. Semont, M.P. Fache, M. Faudon, F. Hery The effects of serotonin on glucocorticoid receptor binding in rat raphe nuclei and hippocampal cells in culture Journal of Neurochemistry 74 2000 406 413
14. R.M. Hirschfeld, D.L. Dunner, G. Keitner, D.N. Klein, L.M. Koran, S.G. Kornstein Does psychosocial functioning improve independent of depressive symptoms?A comparison of nefazodone, psychotherapy, and their combination Biol Psychiatry 51 2002 123 133
15. E.F. Juniper, G.H. Guyatt, F.M. Cox, P.J. Ferrie, D.R. King Development and validation of the Mini Asthma Quality of Life Questionnaire Eur Respir J 14 1999 32 38
16. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
17. T. Kanai, H. Takeuchi, T.A. Furukawa, R. Yoshimura, T. Imaizumi, T. Kitamura, K. Takahashi Time to recurrence after recovery from major depressive episodes and its predictors Psychol Med 33 5 2003 839 845
18. T.M. Kashner, T.J. Carmody, T. Suppes, A.J. Rush, M.L. Crismon, A.L. Miller Catching-up on health outcomes the Texas Medication Algorithm Project Health Serv Res 38 2003 311 331
19. W. Katon, M.D. Sullivan Depression and chronic medical illness J Clin Psychiatry 51 Suppl 1990 3 11 discussion 12-14
20. R.C. Kessler, K.A. McGonagle, Z. Shanyang, C.B. Nelson, M. Hughes, S. Ashleman Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United StatesResults from the National Comorbidity Survey Arch Gen Psychiatry 51 1994 8 19
21. L.M. Koran, A.J. Gelenberg, S.G. Kornstein, R.H. Howland, R.A. Friedman, C. DeBattista Sertraline versus imipramine to prevent relapse in chronic depression J Affect Disord 65 2001 27 36
22. S.J. Lane, T.H. Lee Mechanisms of corticosteroid resistance in asthmatic patients International Archives of Allergy & Immunology 113 1997 193 195
23. M.T. Lowy, A.T. Reder, J.P. Antel, H.Y. Meltzer Glucocorticoid resistance in depression the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone American Journal of Psychiatry 141 1984 1365 1370
24. C.G. Lyketsos, G.C. Lyketsos, S.C. Richardson, A. Beis Dysthymic states and depressive syndromes in physical conditions of presumably psychogenic origin Acta Psychiatr Scand 76 1987 529 534
25. A. Mascia, S. Frank, A. Berkman, L. Stern, L. Lampl, M. Davies Mortality versus improvement in severe chronic asthma Physiologic and psychologic factors Ann Allergy 62 1989 311 317
26. I.W. Miller, G.I. Keitner, A.F. Schatzberg, D.N. Klein, M.E. Thase, A.J. Rush The treatment of chronic depression, part 3 psychosocial functioning before and after treatment with sertraline or imipramine J Clin Psychiatry 59 1998 608 619
27. M. Morgan, D.A. Khan Asthma epidemiology, burden, and quality of life E.S. Brown Advances in Psychosomatic Medicine Asthma - Social and Psychological Factors and Psychosomatic Syndromes 2003 Karger Publishers. Basel Switzerland 1 15
28. V.A. Nejtek, E.S. Brown, D.A. Khan, J. Moore, J. Van Wagner, D.C. Perantie Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic Ann Allergy Asthma Immunol 87 2001 129 133
29. C.M. Pariante, A. Makoff, S. Lovestone, S. Feroli, A. Heyden, A.H. Miller, R.W. Kerwin Antidepressants enhance glucorticoid receptor function in vitro by modulating the membrane steroid transporter Br J Pharmacol 134 2001 1335 1343
30. C.M. Pariante, A.S. Papadopoulos, L. Poon, A.J. Cleare, S.A. Checkley, J. English Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers Psychopharmacology 177 2004 200 206
31. C. Picado, J.M. Montserrat, J. de Pablo, V. Plaza, A. Agusti-Vidal Predisposing factors to death after recovery from a life-threatening asthmatic attack J Asthma 26 1989 231 236
32. L.P. Riso, M.E. Thase, R.H. Howland, E.S. Friedman, A.D. Simons, X.M. Tu A prospective test of criteria for response, remission, relapse, recovery and recurrence in depressed patients treated with cognitive behavior therapy J Affect Disord 43 1997 131 142
33. R.G. Robinson, S.K. Schultz, C. Castillo, T. Kopel, J.T. Kosier, R.M. Newman Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke A placebo-controlled, double-blind study Am J Psychiatry 157 2000 351 359
34. A.J. Rush, C.M. Gullion, M.R. Basco, R.B. Jarrett, M.H. Trivedi The Inventory of Depressive Symptomatology (IDS) Psychometric properties Psychol Med 26 1996 477 486
35. A.J. Rush, N.D. Ryan Current and emerging therapeutics for depression K.L. Davis D. Charney J.T. Coyle C. Nemeroff Neuropsychopharmacology. The Fifth Generation of Progress 2002 Lippincott Williams & Wilkins Philadelphia 1081 1095
36. A.J. Rush, M.H. Trivedi, T.J. Carmody, H.M. Ibrahim, J.C. Markowitz, I.K. Gabor Self-reported depressive symptom measures Sensitivity to detecting changein a randomized, controlled trial of chronically depressed, nonpsychotic outpatients Neuropsychopharmacology 30 2005 405 416
37. A.J. Rush, M.H. Trivedi, H.M. Ibrahim, T.J. Carmody, B. Arnow, D.N. Klein The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR) a psychometric evaluation in patients with chronic major depression Biol Psychiatry 54 2003 573 583
38. G. Sachs, K. Spiess, G. Moser, A. Prager R Kunz, G. Schernthaner Glycosylated hemoglobin and diabetes-self monitoring (compliance) in depressed and nondepressed type I diabetic patients Psychother Psychosom Med Psychol 41 1991 306 312
39. M.D. Sanger The treatment of anxiety and depression in the allergic patientCase Report Ann Allergy 27 1969 506 510
40. J. Schwartz, D. Gold, D.W. Dockery, S.T. Weiss, F.E. Speizer Predictors of asthma and persistent wheeze in a national sample of children in the United States Association with social class, perinatal events, and race Am Rev Respir Dis 142 1991 555 562
41. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller The Mini-International Neuropsychiatric Interview (M.I.N.I.) the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59Suppl 20 Suppl 1998 22 33
42. A.D. Simons, G.E. Murphy, J.L. Levine, R.D. Wetzel Cognitive therapy and pharmacotherapy for depressionSustained improvement over one year Arch Gen Psychiatry 43 1986 43 48
43. R.C. Strunk, D.A. Mrazek, G.S.W. Fuhrmann, J.F. LaBrecque Physiologic and psychological characteristics associated with deaths due to asthma in childhood JAMA 254 1985 1193 1198
44. M.E. Thase, M. Fava, U. Halbreich, J.H. Kocsis, L. Koran, J. Davidson A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia Arch Gen Psychiatry 53 1996 777 784
45. M.E. Thase, A.D. Simons, J. McGeary, J.F. Cahalane, C. Hughes, T. Harden, E. Friedman Relapse after cognitive behavior therapy of depression potential implications for longer courses of treatment Am J Psychiatry 149 1992 1046 1052
46. M.H. Trivedi, A.J. Rush, H.M. Ibrahim, T.J. Carmody, M.M. Biggs, T. Suppes The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders a psychometric evaluation Psychol Med 34 2004 73 82
47. K.B. Weiss, S.D. Sullivan The health economics of asthma and rhinitisI. Assessing the economic impact J Allergy Clin Immunol 107 2001 3 8
48. K.B. Weiss, D.K. Wagener Changing patterns of asthma mortality Identifying target populations at high risk JAMA 264 13 1990 1683 1687
49. M. Weitzman, S.L. Gortmaker, A.M. Sobol, J.M. Perrin Recent trends in the prevalence and severity of childhood asthma JAMA 268 19 1992 2673 2677
50. M.A. Whooley, A.L. Avin, J. Miranda, W.S. Browner Case-finding instruments for depression Two questions are as good as many J Gen Med 12 1997 439 445
51. R. Wolfinger, M. O'Connell Generalized linear models a pseudo-likelihood approach J Statist Comput Simul 48 1993 233 243
52. T. Zielinski, E.S. Brown Depression in patients with asthma E.S. Brown Advances in Psychosomatic Medicine Asthma - Social and Psychological Factors and Psychosomatic Syndromes 2003 Karger Publishers. Basel Switzerland 42 50